DOLSTEN MIKAEL received a stock award from ROCKET PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/6/2026ACC: 0001140361-26-027679
Director
Since Sep 2024
+87.72K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
87.72K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.86K
Price / share
—
Trade value
—
% of position
51.7%
6/18/2026
44.22K→67.08K
Total
Net shares
+22.86K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/18/2026 | A · Award | +22.86K | — | — | 51.7% | 44.22K | 67.08K |
| Total | +22.86K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
64.86K shares
Shares
+64.86K
Strike price
3.35
Held after
64.86K
Exercisable
—
6/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock64.86K shares | 6/18/2026 | A · Award | +64.86K | 3.35 | — | 64.86K |